Search results
Primary Wave Music Founder & CEO Larry Mestel: “Most of our competitors are only interested in a...
Music Ally· 5 days ago“The Home Of Legends” is how Primary Wave Music, set up in 2006, wants itself to be understood. It...
Up-close with the 1974 Martin guitar that Eric Clapton used to write Wonderful Tonight
Guitar World via Yahoo News· 4 days agoEric Clapton’s Wonderful Tonight is one of the great love songs of our time. So when the guitar he...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 2 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 6 days agoThe chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as...
Wales' first minister set to lose confidence vote
BBC via AOL· 3 days agoThe Tories knew that before they tabled this motion which as of yesterday, we have been told that they are refusing to pair with us." She added: "This is...
Engineered bacteria deliver chemotherapy directly to tumors
Medical Xpress· 2 days agoNow, researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary approach to cancer treatment—one that is a more targeted ...
‘I don’t feel gendered’: Rachel Cusk’s most radical novel yet makes the familiar strange – and moves...
The Conversation· 6 days agoRachel Cusk’s twelfth novel is strange, compelling and ferociously intelligent. It explores artists, mothers and daughters, and the ‘blankness of spirituality’ on the other side of gender.
Despite Temper Tantrum, Youngkin Cannot Reverse Va's Climate Progress
Natural Resources Defense Council· 3 days agoDespite the recent reminder to our nation that no chief executive is above the law or exempt from...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 19 hours agoNEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody
Switzerland: Parliament must respect landmark climate case
Amnesty International· 4 days agoAhead of the Swiss parliament’s vote on 5 June, concerning a motion not to further comply with the European Court of Human Rights’ (ECtHR) landmark ruling in the Senior Women for Climate case ...
